Andrographolide-loaded nanoparticles for brain delivery: Formulation, characterisation andin vitropermeability using hCMEC/D3 cell line

    loading  Checking for direct PDF access through Ovid


Graphical abstractHighlightsAndrographolide was loaded into albumin and poly-ethylcyanoacrylate nanoparticles.Size, zeta-potential, polydispersity and morphology were investigated.Blood brain barrier permeability was assessed using in vitro cell based model.UPLC-MS/MS method was developed and validated according to EMA/FDA guidelines.Albumin nanoparticles improved permeation maintaining the integrity of cell layer.Andrographolide (AG) is a major diterpenoid of the Asian medicinal plant Andrographis paniculata which has shown exciting pharmacological potential for the treatment of inflammation-related pathologies including neurodegenerative disorders. Conversely, the low bioavailability of AG still represents a limiting factor for its use. To overcome these limitations, AG was loaded into human serum albumin based nanoparticles (HSA NPs) and poly ethylcyanoacrylate nanoparticles (PECA NPs). HSA NPs were prepared by thermal (HSAT AG NPs) and chemical cross-linking (HSAC AG NPs), while PECA AG NPs were produced by emulsion-polymerization. NPs were characterized in terms of size, zeta (ζ)-potential, polydispersity, and release studies of AG. In addition, the ability of free AG and AG-loaded in PECA and HSAT NPs to cross the blood-brain barrier (BBB) was assessed using an in vitro BBB model based on human cerebral microvascular endothelial cell line (hCMEC/D3). For BBB drug permeability assays, a quantitative UPLC-MS/MS method for AG in Ringer HEPES buffer was developed and validated according to international regulatory guidelines for industry. Free AG did not permeate the BBB model, as also predicted by in silico studies. HSAT NPs improved by two-fold the permeation of AG while maintaining the integrity of the cell layer, while PECA NPs temporarily disrupted BBB integrity.

    loading  Loading Related Articles